BioSpace News Archive

Craniomaxillofacial Devices Market to Reach USD 3.92 Billion By 2027 | Industry Trend – Developments in device technology such as 3D Printing technology

The global Craniomaxillofacial Devices Market is expected to reach USD 3.92 Billion by 2027, according to a new report by Emergen Research.

January 25, 2022
·
7 min read
NGS Sample Preparation Market Size to be Valued at USD 6.63 Billion by 2027 | Industry Trend – High demand in the consumer genomics sector

The Global NGS Sample Preparation Market size is projected to reach USD 6.63 billion in 2027.

January 25, 2022
·
7 min read
Pharm Country

New Study Validates Benefits of Convalescent Plasma for Some COVID-19 Patients

Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study shows.

January 25, 2022
·
5 min read
Hepatitis A Vaccine - Rising Health Awareness Among People Due To High Prevalence Of Diseases Is A Major Factor Expected To Positively Impact Market Revenue Growth Going Ahead | Reports and Data

The industry analysis report is considered a valuable source of information about the global Hepatitis A Vaccine industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 25, 2022
·
6 min read
Revenue Growth Of The Global Ostomy Care Bag Market Is Being Fueled By The Increasing Prevalence Of Inflammatory Bowel Disease, Public Awareness Of Ostomy/Stoma Care, Colorectal Cancer And The Availability Of Treatment Equipment In The Market

The industry analysis report is considered a valuable source of information about the global Ostomy Care Bag industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 25, 2022
·
6 min read
Defymed receives approval to start its pilot clinical study with ExOlin®: the promise of a physiological treatment for diabetic patients

The French authorities validate the start of the therapeutic trial to evaluate the safety of the ExOlin® device for patients suffering from poorly controlled type 1 diabetes with severe glycaemic fluctuations and prone to severe hypoglycaemia.

January 25, 2022
·
5 min read
Macomics Announces Five Additional Internationally Renowned Advisors with Immuno-oncology and Clinical Expertise

They join Prof. Michele De Palma and Dr Jackie Doody world recognised experts in the fields of immuno-oncology, and Dr John Haurum who has over two decades’ experience in the international biotech industry, most recently as Chief Executive Officer of F-star.

January 25, 2022
·
4 min read
Business

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2021 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2021 financial results conference call and webcast for 5:00 a.m. Pacific Time ( 8:00 a.m. Eastern Time ) on Friday, February 11, 2022.

January 25, 2022
·
1 min read
Recurrent Atrial Fibrillation Market Size to Reach USD 25.93 Billion by 2027 Growing at a CAGR of 13.2% | Industry Trend – Advancements in Device Technology

The global Recurrent Atrial Fibrillation Market is expected to reach USD 25.93 Billion by 2027, according to a new report by Emergen Research.

January 25, 2022
·
8 min read
Virtual Clinical Trial Market By Study Design, By Indication, and By Region Forecast To 2028 – Reports and Data

The industry analysis report is considered a valuable source of information about the global Virtual Clinical Trial industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 25, 2022
·
7 min read